301093 Jiangsu Hualan New Pharmaceutical Material
- 23.05
- +0.10+0.44%
Jiangsu Hualan New Pharmaceutical Material News
Hualan Co., Ltd. (301093.SZ): Termination of the 2022 restricted Stocks incentive plan.
On December 27, Gelonghui reported that Hualan Co., Ltd. (301093.SZ) held the thirty-first meeting of the fifth Board of Directors and the twenty-eighth meeting of the fifth Supervisory Board on December 27, 2024, to review and approve the proposal to terminate the implementation of the 2022 restricted stock incentive plan and to buy back and cancel the restricted stocks. Given the significant changes in the company's internal and external operating environment compared to when the incentive plan was formulated, there is considerable uncertainty in achieving the subsequent performance assessment targets set in this incentive plan, making it difficult to achieve the expected incentive goals and effects by continuing the implementation of this incentive plan.
Hualan Co., Ltd. (301093.SZ) intends to postpone the "Research and Development Center Construction Project" to June 30, 2025.
On December 27, 2023, Gelonghui reported that Hualan Co., Ltd. (301093.SZ) announced that based on the current progress and actual situation of the fundraising investment projects, the company decided to postpone the "Research and Development Center Construction Project", extending the date for the project to reach the designated usable state from December 31, 2024, to June 30, 2025, without changing the implementation主体、implementation method, use of raised funds, and investment scale.
Express News | Today, a total of 83 stocks on the A-shares market experienced large-scale trades, with china international capital corporation, contemporary amperex technology, and proya cosmetics having the highest transaction volumes.
Hualan Co., Ltd.: Report for the third quarter of 2024
Hualan Shares (301093.SZ): Some of the raised funds for investment projects are planned to be postponed.
On September 26, GeLongHui announced that Hualan Shares (301093.SZ) held the twenty-seventh meeting of the fifth board of directors and the twenty-fourth meeting of the fifth supervisory board on September 26, 2024, and approved the "Proposal on Postponing Some Raised Funds Investment Projects." The company, based on the current progress and actual situation of the raised funds investment projects (referred to as the "investment projects" below), after careful consideration and without changes to the implementation subject, implementation method, use of raised funds for investment, and investment scale of the investment projects, decided to "Automatic, Asia vets Factory Renovation Project" and "Expansion of Pre
Hualan Co., Ltd. (301093.SZ): has repurchased 0.99% of shares to date.
On September 2, GlobeNewswire announced that Hualan Shares (301093.SZ) has disclosed that as of August 31, 2024, the company has repurchased a total of 1,281,000 shares of its own stock through a repurchase special securities account using its own funds through centralized bidding trading. The repurchased shares account for 0.99% of the company's total share capital, with the highest purchase price of 20.164 yuan per share and the lowest purchase price of 18.066 yuan per share. The total amount paid is 24,692,847.100 yuan (excluding transaction costs). The progress of the repurchase complies with relevant laws, regulations, and the company's share repurchase program requirements.
Hualan Share (301093): Order is expected to gradually be imported with orderly recovery in the second quarter.
1Q24 is under pressure, 2Q24 is improving. The company announced that the revenue, net profit attributable to the mother, and non-net profit for 1H24 were 28.4, 3.7, and 2.4 billion yuan (-6%, -38%, -31% yoy), respectively, with 2Q24 included.
Hualan Co., Ltd.: Summary of the 2024 Semi-Annual Report
Hualan shares: 2024 semi-annual report
Hualan Shares (301093.SZ) released its half-year performance, with a net income of 36.9762 million yuan, a decrease of 38.41%.
HuaLan Co., Ltd. (301093.SZ) released its 2024 interim report, with a revenue of 0.284 billion...
Express News | Hualan Co., Ltd.: Net income in the first half of 2024 decreased by 38.41% year-on-year.
Express News | Hualan shares: plans to repurchase shares of 40 million yuan to 80 million yuan.
Express News | 30 companies have disclosed their progress on share repurchases, with zhejiang huatong meat products, guangdong saca precision manufacturing, and create technology & science having the highest repurchase plan amounts.
Citic Securities Starts Jiangsu Hualan New Pharmaceutical Material at Buy With 25 Yuan Price Target
Express News | Hualan shares: plans to buy back company shares for 40-80 million yuan.
Hualan Shares (301093.SZ) plans to jointly establish a joint venture with Dangsheng to operate the business of wet heat sterilization medical packaging materials.
Hualan Shares (301093.SZ) announced that the company has recently cooperated with Xiamen Dangsheng New Materials Co., Ltd. (hereinafter referred to as "Dangsheng")...
Express News | Hualan Shares: Plans to invest in setting up a joint venture company.
Hualan Technology (301093.SZ): plans to extend the "Research and Development Center Construction Project" to December 31, 2024.
On June 25, Guosen Securities reported that Hualan Holdings (301093.SZ) held the 24th meeting of its fifth board of directors and the 21st meeting of its fifth supervisory board. They approved the proposal regarding the postponement of some raised capital investment projects. Based on the current progress and actual situation of the investment projects, and without any changes in the implementation entities, implementation methods, investment purposes, and investment scale of the raised capital investment projects, the company carefully studied and decided to postpone the 'Research and Development Center Construction Project'.
Hualan Co., Ltd. (stock code: 301093.SZ) will pay a dividend of 6 yuan for every 10 shares in 2023, with a registration date of June 27.
Hualan Shares (301093.SZ) announced that the company will implement annual equity distribution for 2023, with a ratio of 10 shares per...
Developing new business growth points, Hualan Stock (301093.SZ) plans to invest 1.47 million yuan to jointly establish a joint venture company with Shanghai Kelai Mechatronics Engineering.
Zhitoon Finance App news: Hualan Shares (301093.SZ) announced that the company will establish a joint venture with Shanghai Kelai Mechatronics Engineering to specialize in developing, manufacturing, selling, industrial automation production system equipment, mechatronics products and equipment, electronic control, design and manufacturing, installation and commissioning, maintenance and other business in the medical industry. The registered capital of the joint venture is 3 million yuan, and Hualan Shares will contribute 1.47 million yuan of its own funds, accounting for 49% of the registered capital of the joint venture. The announcement stated that this external investment is beneficial to the development of new business growth points for Hualan Shares and to expand its influence.
No Data
